PURPOSE: We investigated the characteristics of lung allocation and outcomes of lung transplant (LTx) according to the Korean urgency status. MATERIALS AND METHODS: LTx registration in the Korean Organ Transplantation Registry (KOTRY) began in 2015. From 2015 to June 2017, 86 patients who received LTx were enrolled in KOTRY. After excluding one patient who received a heart-lung transplant, 85 were included. Subjects were analyzed according to the Korean urgency status. RESULTS: Except for Status 0, urgency status was classified based on partial pressure of oxygen in arterial blood gas analysis and functional status in 52 patients (93%). The wait time for lung allograft was well-stratified by urgency (Status 0, 46.5±59.2 days; Status...
Purpose: Data on the distribution and impact of panel reactive antibodies (PRA) and donor specific a...
Lung transplantation for end-stage lung disease results in prolonged actuarial survival and improved...
Lung transplantation is widely accepted as the only viable treatment option for patients with end-st...
OBJECTIVE: Lung transplantation (LTx) is the only option for end-stage lung disease refractory to me...
BackgroundEvaluating allocation system effects on lung transplantation and determining systemic flaw...
BACKGROUND: The Korean Organ Transplantation Registry (KOTRY) began to register lung transplants in ...
BACKGROUND: On May 4, 2005, the system for allocation of deceased donor lungs for transplant in the ...
Lung transplantation for end-stage lung disease results in prolonged survival and improved pulmonary...
BackgroundEvaluating allocation system effects on lung transplantation and determining systemic flaw...
BACKGROUND: The purpose of the study was to investigate the impact of the lung allocation score (LAS...
BACKGROUND: Throughout the world, the scarcity of donor organs makes optimal allocation systems nece...
Background: The use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantatio...
Lung transplantation is an established therapy for end-stage pulmonary disorders in selected patient...
Background: In lung transplantation, human leukocyte antigen (HLA) compatibility is not included in ...
Background: Lung transplantation is a life-saving procedure in patients with end-stage lung disease,...
Purpose: Data on the distribution and impact of panel reactive antibodies (PRA) and donor specific a...
Lung transplantation for end-stage lung disease results in prolonged actuarial survival and improved...
Lung transplantation is widely accepted as the only viable treatment option for patients with end-st...
OBJECTIVE: Lung transplantation (LTx) is the only option for end-stage lung disease refractory to me...
BackgroundEvaluating allocation system effects on lung transplantation and determining systemic flaw...
BACKGROUND: The Korean Organ Transplantation Registry (KOTRY) began to register lung transplants in ...
BACKGROUND: On May 4, 2005, the system for allocation of deceased donor lungs for transplant in the ...
Lung transplantation for end-stage lung disease results in prolonged survival and improved pulmonary...
BackgroundEvaluating allocation system effects on lung transplantation and determining systemic flaw...
BACKGROUND: The purpose of the study was to investigate the impact of the lung allocation score (LAS...
BACKGROUND: Throughout the world, the scarcity of donor organs makes optimal allocation systems nece...
Background: The use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantatio...
Lung transplantation is an established therapy for end-stage pulmonary disorders in selected patient...
Background: In lung transplantation, human leukocyte antigen (HLA) compatibility is not included in ...
Background: Lung transplantation is a life-saving procedure in patients with end-stage lung disease,...
Purpose: Data on the distribution and impact of panel reactive antibodies (PRA) and donor specific a...
Lung transplantation for end-stage lung disease results in prolonged actuarial survival and improved...
Lung transplantation is widely accepted as the only viable treatment option for patients with end-st...